主动脉内膜感染:诊断和治疗。

IF 0.8 Q4 PERIPHERAL VASCULAR DISEASE
Young-Wook Kim
{"title":"主动脉内膜感染:诊断和治疗。","authors":"Young-Wook Kim","doi":"10.5758/vsi.230071","DOIUrl":null,"url":null,"abstract":"<p><p>Aortic endograft infection (AEI) is a rare but life-threatening complication of endovascular aneurysm repair (EVAR). The clinical features of AEI range from generalized weakness and mild fever to fatal aortic rupture or sepsis. The diagnosis of AEI usually depends on clinical manifestations, laboratory tests, and imaging studies. Management of Aortic Graft Infection Collaboration (MAGIC) criteria are often used to diagnose AEI. Surgical removal of the infected endograft, restoration of aortic blood flow, and antimicrobial therapy are the main components of AEI treatment. After removing an infected endograft, in situ aortic reconstruction is often performed instead of an extra-anatomic bypass. Various biological and prosthetic aortic grafts have been used in aortic reconstruction to avoid reinfection, rupture, or occlusion. Each type of graft has its own merits and disadvantages. In patients with an unacceptably high surgical risk and no evidence of an aortic fistula, conservative treatment can be an alternative. Treatment results are determined by bacterial virulence, patient status, including the presence of an aortic fistula, and hospital factors. Considering the severity of this condition, the best strategy is prevention. When encountering a patient with AEI, current practice emphasizes a multidisciplinary team approach to achieve an optimal outcome.</p>","PeriodicalId":52311,"journal":{"name":"Vascular Specialist International","volume":"39 ","pages":"26"},"PeriodicalIF":0.8000,"publicationDate":"2023-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c6/45/vsi-39-26.PMC10512004.pdf","citationCount":"0","resultStr":"{\"title\":\"Aortic Endograft Infection: Diagnosis and Management.\",\"authors\":\"Young-Wook Kim\",\"doi\":\"10.5758/vsi.230071\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Aortic endograft infection (AEI) is a rare but life-threatening complication of endovascular aneurysm repair (EVAR). The clinical features of AEI range from generalized weakness and mild fever to fatal aortic rupture or sepsis. The diagnosis of AEI usually depends on clinical manifestations, laboratory tests, and imaging studies. Management of Aortic Graft Infection Collaboration (MAGIC) criteria are often used to diagnose AEI. Surgical removal of the infected endograft, restoration of aortic blood flow, and antimicrobial therapy are the main components of AEI treatment. After removing an infected endograft, in situ aortic reconstruction is often performed instead of an extra-anatomic bypass. Various biological and prosthetic aortic grafts have been used in aortic reconstruction to avoid reinfection, rupture, or occlusion. Each type of graft has its own merits and disadvantages. In patients with an unacceptably high surgical risk and no evidence of an aortic fistula, conservative treatment can be an alternative. Treatment results are determined by bacterial virulence, patient status, including the presence of an aortic fistula, and hospital factors. Considering the severity of this condition, the best strategy is prevention. When encountering a patient with AEI, current practice emphasizes a multidisciplinary team approach to achieve an optimal outcome.</p>\",\"PeriodicalId\":52311,\"journal\":{\"name\":\"Vascular Specialist International\",\"volume\":\"39 \",\"pages\":\"26\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2023-09-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c6/45/vsi-39-26.PMC10512004.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vascular Specialist International\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5758/vsi.230071\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascular Specialist International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5758/vsi.230071","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

摘要

主动脉内移植物感染(AEI)是血管内动脉瘤修复(EVAR)中一种罕见但危及生命的并发症。AEI的临床特征从全身无力和轻度发烧到致命的主动脉破裂或败血症。AEI的诊断通常取决于临床表现、实验室检查和影像学研究。主动脉移植物感染协作(MAGIC)标准的管理通常用于诊断AEI。手术切除受感染的内移植物、恢复主动脉血流和抗菌治疗是AEI治疗的主要组成部分。移除受感染的内移植物后,通常进行原位主动脉重建,而不是额外的解剖旁路。各种生物和人工主动脉移植物已被用于主动脉重建,以避免再次感染、破裂或闭塞。每种类型的移植都有其优缺点。对于手术风险高得令人无法接受且没有主动脉瘘证据的患者,保守治疗可能是一种替代方案。治疗结果由细菌毒力、患者状况(包括主动脉瘘的存在)和医院因素决定。考虑到这种情况的严重性,最好的策略是预防。当遇到AEI患者时,目前的做法强调多学科团队方法以实现最佳结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Aortic Endograft Infection: Diagnosis and Management.

Aortic Endograft Infection: Diagnosis and Management.

Aortic Endograft Infection: Diagnosis and Management.

Aortic Endograft Infection: Diagnosis and Management.

Aortic endograft infection (AEI) is a rare but life-threatening complication of endovascular aneurysm repair (EVAR). The clinical features of AEI range from generalized weakness and mild fever to fatal aortic rupture or sepsis. The diagnosis of AEI usually depends on clinical manifestations, laboratory tests, and imaging studies. Management of Aortic Graft Infection Collaboration (MAGIC) criteria are often used to diagnose AEI. Surgical removal of the infected endograft, restoration of aortic blood flow, and antimicrobial therapy are the main components of AEI treatment. After removing an infected endograft, in situ aortic reconstruction is often performed instead of an extra-anatomic bypass. Various biological and prosthetic aortic grafts have been used in aortic reconstruction to avoid reinfection, rupture, or occlusion. Each type of graft has its own merits and disadvantages. In patients with an unacceptably high surgical risk and no evidence of an aortic fistula, conservative treatment can be an alternative. Treatment results are determined by bacterial virulence, patient status, including the presence of an aortic fistula, and hospital factors. Considering the severity of this condition, the best strategy is prevention. When encountering a patient with AEI, current practice emphasizes a multidisciplinary team approach to achieve an optimal outcome.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.10
自引率
11.10%
发文量
29
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信